Guobang Pharma Ltd. (SHA:605507)
China flag China · Delayed Price · Currency is CNY
24.22
+0.36 (1.51%)
Apr 29, 2026, 3:00 PM CST

Guobang Pharma Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
13,33413,71411,5139,81314,79216,111
Market Cap Growth
17.00%19.12%17.32%-33.66%-8.19%-
Enterprise Value
11,56512,46710,2678,30612,68413,589
Last Close Price
23.8624.8020.2316.7624.6026.56
PE Ratio
17.1716.7114.7316.0216.0622.82
Forward PE
-14.8110.9211.33--
PS Ratio
2.192.281.951.832.593.58
PB Ratio
1.531.601.431.322.072.54
P/TBV Ratio
1.591.671.501.392.182.65
P/FCF Ratio
17.1848.7140.07-69.15-
P/OCF Ratio
12.0824.5216.3018.9914.54-
EV/Sales Ratio
1.902.071.741.552.223.02
EV/EBITDA Ratio
8.408.968.098.7410.4813.37
EV/EBIT Ratio
13.0113.6412.2813.2013.3516.66
EV/FCF Ratio
14.9044.2835.74-59.29-
Debt / Equity Ratio
0.110.120.100.130.090.03
Debt / EBITDA Ratio
0.720.720.611.020.550.17
Debt / FCF Ratio
1.283.542.72-3.11-
Net Debt / Equity Ratio
-0.20-0.20-0.22-0.21-0.30-0.31
Net Debt / EBITDA Ratio
-1.29-1.23-1.38-1.67-1.76-1.95
Net Debt / FCF Ratio
-2.28-6.06-6.086.87-9.983.18
Asset Turnover
0.540.550.560.550.690.69
Inventory Turnover
2.892.863.262.983.082.79
Quick Ratio
1.702.151.541.451.932.40
Current Ratio
2.543.182.302.222.753.96
Return on Equity (ROE)
9.00%9.85%10.08%8.36%13.64%14.68%
Return on Assets (ROA)
4.93%5.25%4.94%4.05%7.17%7.83%
Return on Invested Capital (ROIC)
11.06%11.95%12.09%10.13%18.00%19.50%
Return on Capital Employed (ROCE)
10.10%10.10%10.20%8.00%13.20%12.80%
Earnings Yield
5.75%5.99%6.79%6.24%6.23%4.38%
FCF Yield
5.82%2.05%2.50%-2.36%1.45%-3.88%
Dividend Yield
2.50%2.42%2.99%1.80%2.44%2.63%
Payout Ratio
47.10%43.81%24.83%59.05%13.92%47.27%
Buyback Yield / Dilution
1.79%0.66%-0.27%0.24%-9.09%-8.01%
Total Shareholder Return
4.29%3.08%2.73%2.04%-6.65%-5.37%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.